KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
19.24
+0.08 (0.42%)
At close: Apr 28, 2026, 4:00 PM EDT
26.69
+7.45 (38.70%)
Pre-market: Apr 29, 2026, 9:13 AM EDT
KalVista Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2025 | FY 2024 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Apr '25 Apr 30, 2025 | Dec '24 Dec 31, 2024 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 |
| Net Income | -164.29 | -183.44 | - | -126.64 | -92.91 | |
| Depreciation & Amortization | 1.45 | 0.94 | - | 0.82 | 0.72 | |
| Asset Writedown & Restructuring Costs | 1.79 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | -2.8 | -1.55 | - | -1.23 | 1.13 | |
| Stock-Based Compensation | 17.12 | 12.29 | - | 21.92 | 9.92 | |
| Other Operating Activities | 22.86 | 3.82 | - | 0.75 | -1.53 | |
| Change in Accounts Receivable | -3.89 | - | - | - | - | |
| Change in Inventory | -5.14 | - | - | - | - | |
| Change in Accounts Payable | 6.29 | -4.97 | - | 4.32 | 1.11 | |
| Change in Unearned Revenue | 0.96 | 10.56 | - | - | - | |
| Change in Other Net Operating Assets | 3.21 | 9.45 | - | 10.85 | 6.31 | |
| Operating Cash Flow | -122.43 | -152.91 | - | -89.23 | -75.26 | |
| Capital Expenditures | -2.56 | -0.43 | - | -0.04 | -1.2 | |
| Sale (Purchase) of Intangibles | -0.28 | -0.5 | - | -0.4 | - | |
| Investment in Securities | 30.87 | 91.95 | - | -84.28 | 42.61 | |
| Investing Cash Flow | 28.03 | 91.02 | - | -84.72 | 41.42 | |
| Total Debt Issued | 208.57 | - | - | - | - | |
| Net Debt Issued (Repaid) | 208.57 | - | - | - | - | |
| Issuance of Common Stock | 2.88 | 61.69 | - | 97.59 | 57.03 | |
| Other Financing Activities | 32.51 | 98.04 | - | 53.12 | 1.09 | |
| Financing Cash Flow | 243.96 | 159.73 | - | 150.71 | 58.12 | |
| Foreign Exchange Rate Adjustments | -2.75 | 2.64 | - | -1.21 | 1.24 | |
| Net Cash Flow | 146.81 | 100.48 | - | -24.45 | 25.51 | |
| Free Cash Flow | -124.99 | -153.34 | - | -89.27 | -76.46 | |
| Free Cash Flow Margin | -169.79% | - | - | - | - | |
| Free Cash Flow Per Share | -2.32 | -3.09 | - | -2.43 | -2.74 | |
| Levered Free Cash Flow | - | -92.91 | - | -50.27 | -52.01 | |
| Unlevered Free Cash Flow | - | -89.29 | - | -50.27 | -52.01 | |
| Change in Working Capital | 1.43 | 15.04 | - | 15.17 | 7.41 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.